Navigation Links
ADVENTRX Pharmaceuticals Announces Closing of Financing
Date:7/6/2009

SAN DIEGO, July 6 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has completed the previously announced sale of shares of its 5% Series B convertible preferred stock pursuant to a registered direct offering to a single institutional investor, representing gross proceeds of approximately $1.36 million. Twenty-five percent, or approximately $340,250, of the gross proceeds will be placed in an escrow account, which amounts will be released to make the dividend and other payments described below.

The preferred stock is convertible into shares of ADVENTRX's common stock at the option of the investor at a price of $0.1432 per share and will accrue a 5% dividend until July 6, 2014. If the convertible preferred stock is converted at any time prior to July 6, 2014, ADVENTRX will pay the holder an amount equal to the total dividend that would accrue on the convertible preferred stock from the conversion date through July 6, 2014, or $250 per $1,000 principal amount of convertible preferred shares converted, less any dividend payments made with respect to such converted convertible preferred shares.

ADVENTRX plans to use the net proceeds from the offering to fund activities related to seeking FDA approval to market ANX-530 (vinorelbine emulsion) in the United States, including manufacturing-related activities, and for general corporate purposes, including general and administrative expenses.

The shares were sold by ADVENTRX pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC"). A prospectus supplement relating to the offering was filed with the SEC on June 30, 2009. Rodman & Renshaw, LLC, a wholly owned subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: '/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. ADVENTRX Pharmaceuticals to Present at the 18th Annual CIBC Healthcare Conference
2. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIO-Europe Partnering Conference
3. ADVENTRX Pharmaceuticals to Present at the 2007 RBC Capital Markets Healthcare Conference
4. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
5. ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results
6. ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update
7. ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
8. ADVENTRX Grants Exclusive Rights to ANX-514 in South Korea
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
11. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... Owners of Green Ladies Cleaning are very ... home service category. This honor can only be gained by votes from Madison Magazine ... of the products and methods they use daily. Having a home cleaned with all-natural ...
(Date:7/7/2015)... ... ... is a reputable source of authentic tickets for the 2015 CONCACAF Gold Cup Group A ... Toyota Stadium. , The 2015 CONCACAF Gold Cup is now upon us as Group ... American soil, will kick off in Frisco, CA from the Toyota Stadium and will feature ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... The United ... AIDS Action Committee of Massachusetts , and the Multicultural AIDS Coalition $3.78 ... other men who have sex with men (MSM) and transgender women, the groups ...
(Date:7/7/2015)... ... July 07, 2015 , ... Illinois ... board is limited to permit holders. The Medical Cannabis Alliance of Illinois’ (MCAI) ... industry forward and are committed to making sure patients have access to cannabis ...
(Date:7/7/2015)... ... July 07, 2015 , ... Safe Catch is setting ... fish for mercury. Albertsons, Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market and ... “We developed the technology to test every fish for mercury,” said Safe Catch co-founder ...
Breaking Medicine News(10 mins):Health News:Environmentally-Friendly House Cleaning Company Wins Best of Madison Magazine Award 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 2Health News:Panama vs Haiti & USA vs Honduras CONCACAF Group A Tickets at Toyota Stadium: Ticket Down Slashes Ticket Prices for Haiti vs Panama & USA vs Honduras in Frisco/Dallas 3Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 2Health News:CDC Awards Fenway Health, AIDS Action, Multicultural AIDS Coalition $3.78m For ‘Getting To Zero’ HIV Prevention Partnership 3Health News:Cannabis Growers and Dispensaries Form Medical Cannabis Alliance of Illinois 2Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2
... Health services in various hospitals affiliated to GSVM medical ... protest against the OBC quota in elite educational institutions ... doctors and students were continuing with the protest against ... OBCs in higher centres of learning, representatives of agitating ...
... that private doctors have announced their support to the association's ... have decided to close their hospitals and clinics on May ... extended its support to anti-quota agitators, Dr Amita Hapani, IMA ... 70 medical students and junior doctors from Rajkot and Jamnagar ...
... A research conducted by the King’s Collage London, analysed health reports ... war in 2003 with those who took part// in the 1991 ... ,The study findings that are published in The Lancet ... War Syndrome" in British male armed forces personnel deployed to the ...
... Africa was embroiled in a fresh HIV/Aids yesterday and ... diet containing// garlic, olive oil and lemons. ... of HIV victims’, said Treatment activists. ... ‘Instead of objective decision-making about medical subjects, political measures ...
... a delicate operation, a team of doctors here sucessfully removed ... of a 11-month-old (RPT 11-month-old) boy. // ,Dr ... doctors to perform the operation recently, told PTI here that ... aversion to food for the last one-and-a-half months., ,After ...
... women can even lead to Fetal Alcohol Syndrome. Especially ... in the IQ of the offspring-Report of recent analysis. ... more prone to this condition. ,Although deficits ... exposed to high amounts of alcohol during pregnancy, deficits ...
Cached Medicine News:Health News:Prenatal Alcohol Exposure Sets Cognitive Problems After 10 Years 2Health News:Prenatal Alcohol Exposure Sets Cognitive Problems After 10 Years 3
(Date:7/7/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/rt3mhz/deciphering ... "Deciphering Global Major Pharmaceutical Companies, New Outsourcing Demands ... It has been publicly recognized that global ... series of challenges in the recent years. The ... in small molecule product manufacturing; increasingly challenging process ...
(Date:7/7/2015)... 7, 2015   Decision Resources Group ... dialysis patient management in the U.S. versus the ... U.S. and EU5 nephrologists from approximately 1,870 dialysis ... the most commonly used renal medications in dialysis ... considerably between the two regions.      Other ...
(Date:7/7/2015)... BANGALORE , July 7, 2015 ... innovative clinical trial data management solutions, has been featured ... publication named " EDC and eCOA / ePRO Market ... is one of the leading providers of research and ... 22 EDC and eCOA / ePRO tools in the ...
Breaking Medicine Technology:Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 2Deciphering Global Major Pharmaceutical Companies - New Outsourcing Demands and Strategies 3Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 2Similarities And Differences Exist When Comparing U.S. Versus EU5 Dialysis Patient Management 3Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 2Acceliant Ranked Highest in 'Overall Satisfaction' Amongst EDC Providers in ISR Reports' Recent Research 3
... Inc. (Nasdaq: STRM ) today announced financial ... ended January 31, 2011. Highlights for the ... purchase contracts for add-on licenses with existing clients totaling ... recognized during the quarter; Company completed and ...
... N.J., April 12, 2011 Novartis Pharmaceuticals Corporation ... Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) ... treatment of patients with advanced neuroendocrine tumors (NET) ... provided after presentation of data from the everolimus ...
Cached Medicine Technology:Streamline Health® Solutions Reports Q4 Results 2Streamline Health® Solutions Reports Q4 Results 3Streamline Health® Solutions Reports Q4 Results 4Streamline Health® Solutions Reports Q4 Results 5Streamline Health® Solutions Reports Q4 Results 6Streamline Health® Solutions Reports Q4 Results 7Streamline Health® Solutions Reports Q4 Results 8Streamline Health® Solutions Reports Q4 Results 9Streamline Health® Solutions Reports Q4 Results 10Streamline Health® Solutions Reports Q4 Results 11Streamline Health® Solutions Reports Q4 Results 12Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 2Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 3Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 4Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 5Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 6Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 7Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 8Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 9Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin 10
50L...
... Hamilton is precision, ergonomics, and ... hand fatigue with soft non-slip, contoured ... with smooth, light plunger spring action ... and sterilization without the need for ...
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
250L...
Medicine Products: